Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity

Eye

Volumn 24, Issue 5, 2010, Pages 756-763

  Pasadhika, S ^a   Fishman, G A ^a   Choi, D ^b   Shahidi, M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Ganglion cell; Hydroxychloroquine; OCT; Parafoveal; Perifoveal; Retinal toxicity

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EYE EXAMINATION; EYE TOXICITY; FEMALE; HUMAN; IMAGING SYSTEM; LONG TERM EXPOSURE; OPTICAL COHERENCE TOMOGRAPHY; PSYCHOLOGIC TEST; RETINA FOVEA; RETINA INNER PLEXIFORM LAYER; RETINA MACULA LUTEA; THICKNESS;

EID: 77952502358     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.21     Document Type: Article

References (19)

1. Rynes RI. Hydroxychloroquine treatment of rheumatoid arthritis. Am J Med 1988;85:18-22.
2. Wallace DJ. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review. Lupus 1996;5 (Suppl 1):S59-S64.
3. Butler I. Retinopathy following the use of chloroquine and allied substances. Ophthalmologica 1965;149:204-208.
4. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1, 207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997;40:1482-1486.
5. Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 2003;110:1321-1326.
6. Bernstein HN. Chloroquine ocular toxicity. Surv Ophthalmol 1967;12:415-447.
7. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2002;109:1377-1382.
8. Easterbrook M. Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol 1992;27:237-239.
9. Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen Jr AW, Fung WE et al. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 2003;23:503-512.
10. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978;17:1158-1175.
11. Hallberg A, Naeser P, Andersson A. Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol (Copenh) 1990;68:125-130.
12. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye 2010;24:340-346.
13. Bagci AM, Shahidi M, Ansari R, Blair M, Blair NP, Zelkha R. Thickness profiles of retinal layers by optical coherence tomography image segmentation. Am J Ophthalmol 2008;146:679-687.
14. Vajaranant TS, Seiple W, Szlyk JP, Fishman GA. Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology 2002;109:560-568.
15. Ramsey MS, Fine BS. Chloroquine toxicity in the human eye. Histopathologic observations by electron microscopy. Am J Ophthalmol 1972;73:229-235.
16. Kellner U, Kellner S, Weinitz S. Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol 2008;116:119-127.
17. Girkin CA. Relationship between structure of optic nerve/nerve fiber layer and functional measurements in glaucoma. Curr Opin Ophthalmol 2004;15:96-101.
18. Korah S, Kuriakose T. Optical coherence tomography in a patient with chloroquine-induced maculopathy. Indian J Ophthalmol 2008;56:511-513.
19. Rodriguez-Padilla JA, Hedges TR, Monson B, Srinivasan V, Wojtkowski M, Reichel E et al. High-speed ultra-highresolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 2007;125:775-780. (Pubitemid 46919738)